Streetbeat News

Stock Prices

YOSH

Yoshiharu Global has filed for an offering of up to 400,000 shares, as indicated in their 424B4 filing. This move could impact the company's stock price and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:19 am

HLNE

Hamilton Lane (NASDAQ:HLNE) has been added to the S&P MidCap 400, marking a significant growth milestone. The firm, with over $940 billion in assets under management, continues to expand its private markets investment solutions.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:18 am

TLSI

TriSalus Life Sciences (NASDAQ:TLSI) has published research demonstrating that its Pressure-Enabled Drug Delivery (PEDD) method significantly improves the delivery of glass microspheres into liver tumors compared to conventional methods. The study, conducted on a porcine liver tumor model, shows enhanced penetration and potential for more effective cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:14 am

INDV

MRNA

PGNY

The article highlights three oversold health care stocks with potential for growth: Progyny Inc, Indivior PLC, and Moderna Inc. These stocks have RSI values below 30, indicating they may be undervalued. Progyny faced a client termination, Indivior updated on a study, and Moderna received vaccine approval in Canada.

Portfolio Pulse from Avi Kapoor

September 23, 2024 | 11:13 am

OFIX

Orthofix Medical Inc. (NASDAQ:OFIX) presented new spinal fusion products and data at the NASS Annual Meeting, showcasing innovations like the SpinalStim™ device and OsteoStrand™ Plus C graft. These advancements highlight Orthofix's commitment to improving spinal fusion outcomes.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:10 am

ORGS

Orgenesis has announced a 1-for-10 reverse stock split, effective at 5:00 PM Eastern Time on September 24. This corporate action is likely to impact the stock's trading price and liquidity.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:07 am

SKYE

Skye Bioscience has commented on Novo Nordisk's recent announcement of Phase 2a topline data with Monlunabant, expressing confidence in its own Nimacimab clinical development plan. Skye believes the 16-week weight loss data supports the mechanism of action targeting peripheral CB1 receptors.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:05 am

INTC

MU

PLTR

QQQ

SPY

U.S. index futures are slightly up as traders anticipate key catalysts, including Intel's potential investment and Micron's earnings. Intel rose 3% on investment news, while Palantir fell 1.6% due to negative analyst action. The S&P 500 is nearing an all-time high, with positive sentiment from a September rally.

Portfolio Pulse from Shanthi Rexaline

September 23, 2024 | 11:03 am

DAL

UP

Wheels Up announced that lead investors, including Delta Air Lines, CK Wheels LLC, and Cox Investment Holdings, have agreed to extend the lock-up restriction on their shares until September 20, 2025. Kore Capital LLC and Whitebox Advisors LLC also extended the lock-up on 72.5% of their shares.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:00 am

EBF

Ennis, Inc. has declared a quarterly dividend of $0.25 per share and a special one-time dividend of $2.50 per share, indicating strong financial health and potential positive impact on stock price.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 10:35 am